Share this post on:

AlmiRNA(s)DovepressmiR1273p, miR-148b, miR376a, miR376c, miR4093p, miR652, miRsubmit your manuscript | www.dovepress.commiR133a, miR-148bmiRmiR-148b, miR376c, miR4093p, miRmiR-155, miRmiRmiRNotes: This can be a representative sample of 20 recent research identified on a PubMed query (breast cancer blood miRNA miR) that describe person miRNAs or miRNA signatures obtaining prospective application for early illness detection. Studies with fewer than 20 BC circumstances had been excluded. While these signatures mostly reflect larger amounts of circulating miRNAs, some miRNAs are detected at lower levels in blood samples of BC sufferers. Blood collection was performed ahead of surgery unless otherwise indicated. miRNAs shown in bold indicate a recurrent presence in at least three independent research. Abbreviations: BC, breast cancer; DCiS, ductal carcinoma in situ; eR, estrogen receptor; LN, lymph node status; miRNA, microRNA; qRTPCR, quantitative realtime polymerase chain reaction.Breast Cancer: Targets and Therapy 2015:DovepressDovepressmicroRNAs in breast cancerTable two miRNArelated danger loci related to BCGene locus MIR27A SNP rs895919 *C Comments Population Asians Caucasians Jewish BRCA2 carriers Caucasian Asians Caucasians Chinese (young) Chinese Asians Caucasians African Americans African Americans european Americans Chinese Chinese African Americans european Americans African Americans european Americans italian Caucasians Chinese Asians Caucasians Asians Asians Caucasians Chinese Asians Caucasians Chinese Asians Caucasians African Americans African Americans Korean italian and German Asians Caucasians Brazilian Caucasian Chinese and Korean Chinese Chinese African Americans european Americans Asians Caucasians African Americans european Americans African a0023781 Americans African Americans european Americans African Americans european Americans Asians Caucasians Clinical observation No threat Genz-644282 web association Protective dar.12324 increased danger Decreased threat No risk association Decreased threat Decreased danger Decreased threat No risk association No threat association enhanced survival No threat association Decreased overall threat elevated threat increased risk No risk association elevated all round risk Decreased risk of eR+ BC No risk association earlier age of onset No danger association No threat association No threat association No risk association Decreased danger (C allele) No threat association No risk association No danger association No danger association No danger association No risk association No threat association No threat association Lowered risk Lowered threat Survival of HeR2+ situations No risk association Decreased threat No threat association Decreased risk Decreased threat Decreased threat enhanced risk enhanced danger No danger association No risk association No threat association No risk association Decreased risk of eR- BC No threat association increased survival elevated risk of eR- BC No risk association No threat association enhanced overall danger No threat association No risk association Reference 141 142 143 144 35 34 31 145 33 38 38 33 33 146 147 83 38 144 31 36 38 36 31 145 145 148 37 141 149 147 32 36 83 33 31 33 145 33 33rs895819 A/GpremiRNA premiRNA premiRNA MedChemExpress Gilteritinib premiRNAMIR34B cluster MIR100 MIR101-2 MIR106B MIR122A MIR146Ars4938723 T/C rs1834306 G/A rs1053872 C/G rs462480 A/C rs1527423 A/G rs17669 A/G rs2910164 G/C Principal transcript Main transcriptMIRrs2292832 T/GMIR185 MIR196A-rs2008591 C/T rs887205 A/G rs11614913 T/CMIR204 MIR206 MIR219 MIR331 MIRrs7861254 G rs6920648 A/G rs107822 G/A rs.AlmiRNA(s)DovepressmiR1273p, miR-148b, miR376a, miR376c, miR4093p, miR652, miRsubmit your manuscript | www.dovepress.commiR133a, miR-148bmiRmiR-148b, miR376c, miR4093p, miRmiR-155, miRmiRmiRNotes: This really is a representative sample of 20 recent studies found on a PubMed query (breast cancer blood miRNA miR) that describe person miRNAs or miRNA signatures having possible application for early disease detection. Research with fewer than 20 BC cases were excluded. Whilst these signatures mainly reflect greater amounts of circulating miRNAs, some miRNAs are detected at lower levels in blood samples of BC sufferers. Blood collection was performed prior to surgery unless otherwise indicated. miRNAs shown in bold indicate a recurrent presence in a minimum of three independent research. Abbreviations: BC, breast cancer; DCiS, ductal carcinoma in situ; eR, estrogen receptor; LN, lymph node status; miRNA, microRNA; qRTPCR, quantitative realtime polymerase chain reaction.Breast Cancer: Targets and Therapy 2015:DovepressDovepressmicroRNAs in breast cancerTable 2 miRNArelated risk loci related to BCGene locus MIR27A SNP rs895919 *C Comments Population Asians Caucasians Jewish BRCA2 carriers Caucasian Asians Caucasians Chinese (young) Chinese Asians Caucasians African Americans African Americans european Americans Chinese Chinese African Americans european Americans African Americans european Americans italian Caucasians Chinese Asians Caucasians Asians Asians Caucasians Chinese Asians Caucasians Chinese Asians Caucasians African Americans African Americans Korean italian and German Asians Caucasians Brazilian Caucasian Chinese and Korean Chinese Chinese African Americans european Americans Asians Caucasians African Americans european Americans African a0023781 Americans African Americans european Americans African Americans european Americans Asians Caucasians Clinical observation No danger association Protective dar.12324 elevated risk Decreased risk No threat association Decreased danger Decreased threat Decreased risk No risk association No threat association elevated survival No threat association Decreased overall danger elevated risk increased danger No danger association enhanced overall threat Decreased threat of eR+ BC No threat association earlier age of onset No risk association No risk association No danger association No threat association Decreased threat (C allele) No risk association No risk association No risk association No threat association No threat association No danger association No threat association No risk association Lowered threat Decreased danger Survival of HeR2+ circumstances No danger association Decreased danger No danger association Decreased risk Decreased danger Decreased threat increased risk elevated danger No danger association No danger association No threat association No risk association Decreased risk of eR- BC No threat association elevated survival elevated threat of eR- BC No danger association No danger association enhanced all round danger No danger association No danger association Reference 141 142 143 144 35 34 31 145 33 38 38 33 33 146 147 83 38 144 31 36 38 36 31 145 145 148 37 141 149 147 32 36 83 33 31 33 145 33 33rs895819 A/GpremiRNA premiRNA premiRNA premiRNAMIR34B cluster MIR100 MIR101-2 MIR106B MIR122A MIR146Ars4938723 T/C rs1834306 G/A rs1053872 C/G rs462480 A/C rs1527423 A/G rs17669 A/G rs2910164 G/C Primary transcript Principal transcriptMIRrs2292832 T/GMIR185 MIR196A-rs2008591 C/T rs887205 A/G rs11614913 T/CMIR204 MIR206 MIR219 MIR331 MIRrs7861254 G rs6920648 A/G rs107822 G/A rs.

Share this post on: